---
trial_id: 687
discovery_date: 2022-04-24 11:57:52.242921
date: 2022-04-24 11:57:52.242921
title: "A One-Year, Randomized, Double-Masked, Multicenter, Phase III, Two-Arm Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Chinese Patients With Visual Impairment Due to Diabetic Macular Edema"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04058067'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
